Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Virology Stories

2013-05-23 08:27:14

June 19-20, 2013 New York Academy of Sciences, New York, NY ATLANTA, May 23, 2013 /PRNewswire/ -- Inhibikase Therapeutics, Inc., an emerging leader in infectious disease treatments, announced today that it will present new results on its antiviral program to 'prevent' PML at an industry conference sponsored by the PML Consortium (composed of Pfizer, Bristol-Meyers Squibb, Roche and Biogen Idec). JC polyomavirus (JCV) is the causative agent of Progressive Multifocal...

2013-05-22 08:27:27

PRINCETON, N.J., May 22, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that the US Patent and Trademark Office granted patent 8,444,991 entitled "Method of Preparing an Immunologically-Active Adjuvant-Bound Dried Vaccine Composition." The new patent's claims encompass...

2013-05-21 08:48:47

Research to be presented at 3-day AAPS National Biotechnology Conference A novel vaccine study from South Dakota State University (SDSU) will headline the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC). The meeting takes place Monday, May 20 - Wednesday, May 22 at the Sheraton San Diego Hotel and Marina. "The main goal of a vaccine is to stimulate the immune system to fight against a...

2013-05-14 08:34:53

Polyvalent Vaccine Design Stimulates Significant Antibody and T-Cell Responses with 100% Survival Against Multiple Families of Most Lethal Virus Known to Man BLUE BELL, Pa., May 14, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that in a preclinical study of Inovio's SynCon(®) DNA vaccine against Ebola and Marburg filoviruses, labeled "Category A" bioterrorism agents by the U.S. government, the vaccine induced strong and broad immune responses...

2013-05-07 20:23:56

Obtains Promising Vaccine Candidates Against Dengue and Hand, Foot and Mouth Disease, Advancing Takeda's Commitment to Vaccines and Global Health OSAKA, Japan and DEERFIELD, Ill. and FORT COLLINS, Colo., May 7, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and Inviragen, Inc. ("Inviragen") jointly announced today that Takeda, its wholly owned subsidiary Takeda America Holdings, Inc., and Inviragen, Inc. have entered into a definitive agreement for Takeda to...

2013-05-07 16:28:32

SAN DIEGO, May 7, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. Through the publication of CEO notes, I seek to provide shareholders and other interested parties with a level of corporate transparency often absent in the microcap marketplace. In recent notes, I reviewed various topics, including emerging opportunities in cancer and the expansion of our government contract program to create a sepsis...

2013-05-02 17:40:58

Using advanced genetic sequencing technology and analysis, Mayo Clinic vaccine researchers have identified 27 genes that respond in very different ways to the standard rubella vaccine, making the vaccine less effective for a portion of the population. The findings appear today in the online journal PLOS ONE. "This study highlighted the genes potentially responsible for poor response to the rubella vaccine," says Mayo Clinic vaccinologist Gregory Poland, M.D. "We found differences in genes...

2013-04-25 08:34:16

May 11, 2013 Grand Hotel Bristol, Stresa, Italy ATLANTA, April 25, 2013 /PRNewswire/ -- Inhibikase Therapeutics, Inc., an emerging leader in infectious disease, announced today that it will update the scientific and medical community on the development program for IkT-001Pro. IkT-001Pro, a host-directed tyrosine kinase inhibitor in an extended release formulation, is intended to clear JC polyomavirus (JCV) infection, the causative agent of Progressive Multifocal...

2013-04-23 14:57:32

Researchers from Yale University School of Medicine have demonstrated that vesicular stomatitis virus (VSV) is highly competent at finding, infecting, and killing human melanoma cells, both in vitro and in animal models, while having little propensity to infect non-cancerous cells. "If it works as well in humans, this could confer a substantial benefit on patients afflicted with this deadly disease," says Anthony van den Pol, a researcher on the study. The research was published online...

2013-04-22 08:28:34

BETHESDA, Md., April 22, 2013 /PRNewswire-USNewswire/ -- The National Foundation for Infectious Diseases will host the 16(th )Annual Conference on Vaccine Research, April 22-24, 2013, at the Hyatt Regency Inner Harbor in Baltimore, MD. This three-day conference presents high-quality, current reports of scientific progress and best practices in both invited presentations and submitted oral abstracts and posters. The conference brings together the diverse disciplines involved in the research...


Latest Virology Reference Libraries

Virology Journal
2012-04-24 18:40:35

Virology Journal is an open-access peer-reviewed medical journal published by BioMed Central. It covers research related to viruses and the prevention of viral infection (including vaccination, the use of antiviral agents, and gene therapy). Virology Journal was established in 2004 and is edited by Robert F. Garry. The goal of the journal is to cover rapid communications amongst virologists. The journal has not been published without controversy, however. On 21, July 2010, the journal...

2012-04-24 18:35:41

Virology is a peer-reviewed academic journal covering basic research into viruses affecting animals, plants, bacteria and fungi. It includes the molecular biology, structure, assembly, pathogenesis, immunity and interactions viruses have with the host cell. The journal also covers aspects of control and prevention, as well as viral vectors and gene therapy. Virology was established in 1955 and is now published bi-weekly by the Academic Press imprint of Elsevier. Subscribers of Virology...

0_c4753f392575c29d1886d90b7b382782
2011-02-23 21:28:34

A virus is a small infectious agent that replicates inside the living cells of organisms. It is a small infectious agent that can replicate only inside the living cells of organisms. Most are too small to be seen by anything but a microscope and they infect all organisms from animals to plants to bacteria. The first one discovered was the tobacco virus in 1898. Since then around 5,000 viruses have been described in detail although there are millions of different types. They are found in...

70_1a57dceb4fac796cf2ab07fe90a19d10
2011-02-23 21:23:46

Vesicular stomatitis virus (VSV) is a virus in the family Rhabdoviridae. Rabies is in the same family. VSV infects insects and animals and is important to farmers in certain regions of the world where it can infect cattle. It is a common laboratory virus used for studying the Rhabdoviridae family and viral evolution. It is the prototypic member of the vesiculovirus genera of the Rhabdovirus family. The genome is a single molecule of negative-sense RNA that encodes five major proteins.

70_3535864920345861b4838317cda6792c
2011-02-23 21:08:22

Tobacco mosaic virus (TMV) is a positive-sense single stranded RNA virus that infects plants, namely tobacco and other members of the family Solanaceae. It causes characteristic patterns on the leaves. In 1930 it was determined that an infectious agent was determined to be a virus. Adolf Mayer first described the disease in 1883. The disease can be transferred between plants similar to bacterial infections. Dimitri Ivanovski was the first to show that infected sap remained infectious even...

More Articles (18 articles) »